订阅小程序
旧版功能

Immune-related Adverse Events after 2 Years in Patients with Advanced Non-Small-cell Lung Cancer Receiving Extended Immune Checkpoint Inhibitor Therapy.

Journal of Clinical Oncology(2024)

引用 0|浏览9
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要